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Abstract
Pediatric stroke is a rare but highly penetrant disease with a strong genetic background. While there is an increasing number of genome-wide association studies (GWAS) for stroke in adults, such studies for stroke of pediatric onset are lacking.
Here we report the results of the first GWAS on pediatric stroke using a large cohort of 270 family-based trios.
GWAS was performed using the Illumina 370 CNV SNP array and analyzed using the transmission disequilibrium test (TDT) as implemented in PLINK. An enrichment analysis was performed to identify additional true association signals among lower Pvalue signals, and searched for cumulatively associated genes within protein interaction data using dmGWAS. We observed clustering of association signals in four genes belonging to one family of metalloproteinases at high (ADAMTS12 P=2.9×10 -6 , ADAMTS2 P=8.0×10 -6 ) and moderate (ADAMTS13 P=9.3×10 -4 , ADAMTS17 P=8.5×10 
Introduction
Pediatric stroke (PS) is a heterogeneous disorder associated with significant morbidity and mortality. It is recognized as an important childhood disease, with an incidence of 2.6 to 6.4 per 100.000 children per year. 1 Although PS is relatively rare it is devastating to those affected as half of the survivors develop cognitive or motor disabilities. However, genetic predisposition, environmental effects and other risk factors can often not be disentangled due to the complex nature of PS etiology. Furthermore, a large proportion of missing heritability remains to be accounted for. 5 Genome-wide association studies (GWAS) offer a powerful approach to gene function discovery and are the current method of choice to dissect the genetic basis of complex diseases. Up-to-date, studies in families with a known first onset of pediatric stroke are lacking mainly due to limited sample size.
Therefore, we performed a family-based GWAS for pediatric stroke in 270 families from Muenster, Germany comprising affected children and their parents. We identified s e v e r a l single nucleotide polymorphisms (SNPs), which are associated
For personal use only. on October 28, 2017. by guest www.bloodjournal.org From with PS at significance levels P<10 -5 . In addition, we determined potential combined effects of single SNPs contributing to stroke risk that may be missed through conventional single marker or haplotype association. We assessed the complete GWAS dataset under a systems biology aspect incorporating protein interaction information to gain further insight into the biological networks underlying pediatric stroke. 6 The latter analysis highlights the complex interplay of genes at the interface of vascular biology and coagulation in the pathogenesis of PS and supports the need of an extensive analysis of combined genetic and physiological properties of complex diseases.
Methods
The study was approved by the medical ethics committee of the University of From an initial study sample comprising 300 consecutively enrolled families, 293 trios were considered eligible for genotyping after removal of siblings and assessment of DNA quality. Of these, 270 were valid for statistical analysis after filtering for call rate (> 97%), Mendelian inheritance error rate (< 0.1%) and gender prediction match using the GenomeStudio Software (Illumina Inc. V 1.9.4) (Figure 1 ). Potential population stratification was assessed using a population concordance analysis implemented in PLINK V1.06 (supplementary web material). 7 
Genotyping
In the initial analysis, 235 trios were genotyped on Illumina Infinum 370CNV arrays.
35 additional trios were genotyped using its successor, the Infinium 660W chip, due to discontinuation of the 370CNV series. The SNP content overlap between both chip layouts is 89.7%. For statistical analysis, we used all SNPs from the 370CNV chip, accepting a slightly reduced sample size for 36.189 SNPs not present on the 660W chip. This does not pose a statistical bias because the number of observations varies for the transmission disequilibrium test (TDT) dependent on allele frequency and number of heterozygous parents. We tested the validity of integrating genotypes from these chips by running 40 samples on both chips. Allele callings match at 99.48% for common SNPs; thus we conclude that genotypes can be combined. All genotyped samples were assessed for sufficient call rate, gender estimation match, mendelian error fraction and population structure prior to statistical analysis as detailed in the supplementary text and supplementary Figure S4 .
Association analysis
We performed a GWAS using a threshold of P<1×10 -5 for suggestive genome-wide
For personal use only. on October 28, 2017. by guest www.bloodjournal.org From association. P-values were computed using the TDT and validated by 20.000 genedropping permutation runs yielding empirical P-values based on unbiased null distributions (PLINK V1.06). 7 This analysis was carried out for the complete dataset
[n=270] and a subset excluding vascular strokes [n=201].
Systems biology analysis
In a subsequent step, we estimated the amount of true association signals by visual inspection of the QQ plot. Deviating intervals in the QQ plot are considered as indicators for population stratification or similar statistical bias. 8 However, the observed deviation at midrange P-values may also be attributed to the presence of a large number of independent and weakly associated loci that reflect the genetic complexity of the disease. As family studies are immune to population stratification and individuals were ascertained consecutively, selection bias towards secondary phenotypes is unlikely in our experimental setting.
Therefore, we assessed the excess of observed association in an enrichment analysis for abundant stroke-related genes occurring in deviating P-value intervals in the QQ-plot. We assembled a set of stroke-related genes by collecting all gene identifiers that occur with the keyword 'stroke' in Pubmed abstracts (see supplementary web material). A second set of GWAS-derived genes was generated by setting a threshold at P<1×10 -3 in our dataset to generate a set of candidate SNPs, expecting a fraction of 16% among the loci to be true positive associations according to a false discovery rate of 84% derived by Benjamini-Hochberg correction. These candidate SNPs were then assigned to one or more genes using a linkage disequilibrium (LD) mapping approach and the postgwas R package as described in the supplementary material. Overrepresentation of stroke-associated
For personal use only. on October 28, 2017. by guest www.bloodjournal.org From genes within the GWAS-set was determined by Fisher's exact test using R. To account for potential publication bias in this procedure, we performed a permutation test with 100.000 random samples matching the size of the stroke-related gene set which were drawn from the entire human genome (Ensembl database, Homo sapiens genes GRCh37.p5). The overlap with the GWAS-derived set of genes was computed and results in an approximate null distribution that is used for comparison to the observed overlap for the stroke-related set (supplementary Figure S1 ).
Secondly, we investigated the data regarding their relatedness within protein interaction networks to identify low-risk variants that act jointly on an intermediate phenotype (i.e. biological pathway). We used dmGWAS 6 , a method that searches for densely connected modules within protein-interaction graphs, where members of such modules are constrained towards an accumulation of strong association signals.
In a primary step, a representative P-value was assigned to each gene which is the smallest of (1) all intragenic SNPs and (2) SNPs with an LD r 2 >0.3. Afterwards, the dense module search of dmGWAS was performed with an interaction dataset and parameter settings as described in the supplementary appendix. From the resulting set of modules, we extracted the top three for visualization. In addition, we used Gene Ontology (GO) and pathway data from REACTOME as established categorization databases in an enrichment analysis to identify primary biological functions of the resulting network. We identified enriched terms in the network of proteins using the overrepresentation analysis features of the STRING database web interface. 9 Proteins containing these terms are colorized accordingly in the graphical plot.
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Results
Genome-wide association analysis GWAS was conducted in the complete dataset of 270 incident stroke families and a subset of nonvascular stroke (n=201). 334.581 SNPs provided valid association signals after applying missingness tests (>25% genotyped) and allele frequency filtering (>1%), resulting in a signal intensity plot as shown in Figure 2 for suggestive genome-wide significance (rs1364044 P=2.9×10 -6 ; rs2084898
P=4.3×10 -6 ; rs469568 P=8.0×10 -6 ; rs4663691 P=9.8 ×10 -6 ), which are summarized in Table 1 . Three SNPs are intragenic; two of them are located in genes that belong to the ADAMTS family, one is proximate to COPS8. As shown in Table 1 , all loci are robust to permutation testing and range at medium to high allele frequencies (12 to 48%) in the population resulting in a large number of heterozygous parents and reliable T/U ratios. Comparative display of subphenotype P-values and linkage disequilibrium information is further shown in regional plots (supplementary Figure 2) .
Due to the smaller subphenotype datasets, P-values drop approximately one order of magnitude but do not show major discrepancies due to subphenotype stratification (Table 1) .
Systems biology analysis
In the QQ-plot (Figure 3) , we identified an interval between 10 -3 < P < 10 -5 showing an excess of observed loci beside the peak signal range. In absence of confounding 1 0 effects, this suggests the presence of true association. To confirm that this midrange deviation is caused by association with the stroke phenotype, we performed an enrichment analysis with stroke-related genes as described in the methods section.
We observed that 15.7% of moderately associated loci from our study occur in the set of stroke-related genes (1.8% vice versa), which is more than expected and reaches the threshold of significance as assessed by Fisher exact-test (P= .019).
Additional permutation testing confirmed the findings at P < .0005 (supplementary web material).
Subsequently, we assessed the entire GWAS dataset for dysregulated molecular P= .055) as listed in supplementary Table S1 . DMD as a prominent cardiovascular risk gene is not addressed here because it spans a large genomic region and resides on the X-chromosome, and is thus likely a false positive association, which requires careful interpretation.
Overlap with GWAS signals previously identified for adult stroke
To investigate whether some genetic components overlap between phenotype windows, we searched for loci that were previously reported to be associated with adult stroke in the literature. We extracted 710 SNP loci as putative candidates and mapped them to our dataset using a proxy SNP approach (supplementary web material). However, none of these loci reached significance after correction for multiple testing.
Discussion
Here we present results of the first GWAS on pediatric stroke in 270 nuclear families.
To our knowledge, this cohort represents the largest study sample currently available worldwide. We identified several novel susceptibility genes that directly relate to coagulation and vascular biology. The most important finding is the identification of four members of the ADAMTS gene family at confident association levels. While SNPs residing in ADAMTS2 and 12 are strongly associated (P = 8.0×10 -6 , P= In the clinical setting, ADAMTS13 has been proposed as a target for treatment of stroke due to its negative regulation of thrombosis and inflammation. 16 In addition, acquired TTP has been described in the presence of IgG, IgA or IgM antibodies inhibiting ADAMTS13 activity. In these cases the inhibitory antibody effect could be overridden by administration of recombinant ADAMTS13 concentrate. 17 In an experimental study, Zhao and colleagues reported that infusion of high dose ADAMTS13 concentrates administered immediately before reperfusion injury significantly reduces infarct volume in mice and improves functional outcome without evidence of hemorrhage. 16 Taken together, these studies render ADAMTS13 an attractive candidate for clinical treatment of stroke and a potential diagnostic kit that incorporates genetic variation as predictors for stroke risk.
Several other genes from the ADAMTS family, such as ADAMTS7, have already been connected to endothelial differentiation and matrix physiology. 18 Recent metaanalyzes revealed an association of ADAMTS7 and 8 with pulse pressure 19 and coronary artery disease 20 at genome-wide significance. Notably, ADAMTS7 is a direct phylogenetic neighbor of ADAMTS12 (supplementary Figure S3) , which is the 1 3 gene with the most stringent association in our study. The large amount of sequence identity between the two genes is a strong indicator of redundant functionality.
ADAMTS18 has been shown to be protective against stroke in mice as it is capable of dissolving platelet aggregates. 21 Thus, a general role of the ADAMTS gene family in extracellular matrix biology and coagulation is conceivable based on our data and existing knowledge. Nevertheless, for ADAMTS2 and ADAMTS12, the susceptibility genes with most significant association signals, there is no information on biological function available yet. ADAMTS2 is known to be involved in procollagen processing, inhibition of angiogenesis and tumor growth. 22 ADAMTS12 shows similar functionality, being involved in the degradation of cartilage oligomeric matrix protein and showing anti-angiogenic and tumor suppressive properties 23 as well as a modest association with heart failure. 24 However, the mechanisms through which the genetic variants in ADAMTS genes lead to pediatric stroke remain unknown.
We observed further loci at suggestive genome-wide significance that do not map unambiguously to a distinct gene. One variant tags a LD block containing the genes TRIM29, OAF and POU2F3 and the other variant resides in an intergenic region proximal to COPS8. The TRIM29 block is a cassette of genes involved in regulation of transcription. COPS8 (as part of the protein complex COP9) is a regulator of cyclooxogenase-2 25 and might therefore influence coagulation.It has been argued that variants identified in GWAS explain only a small proportion of the genetic variance underlying most complex traits. 1 4 protein interactome that conjoins loci of strong to moderate significance. This network provides first insights into the interplay of putative causative genes on a proteome level and represents a first attempt to understand gene variants in the context of whole cells and cellular communication. Accordingly, we found interacting components of extracellular matrix biology (ADAMTS2, CHRM3, PFN2) and coagulation signaling (CALM1, PIK3CB, PFN2) that suggest a complex relation between multiple causative genes with low to medium individual effects.
Significance of these genes is further substantiated by the literature. For PIK3CB, crucial function in platelet aggregation and adhesion to fibrinogen has been shown with targeted alleles in mice. 27 Available antithrombotic therapy targeting PI3K 28 could be established in the future as a treatment conditional on genetic testing, given successful replication of our results. For ANGPT1, lethal vascular defects have been observed in mouse knockout models, and a special role in injured vasculature has been proposed. 29 Interestingly, there is an additional peak at P=2.0×10 -4 with the next gene, ANGPT2, residing 380kb apart, which was not included in the dmGWAS analysis due to our restrictive SNP to gene mapping. CHRM3, also known as muscarinic receptor 3, plays a major role in dilation of coronary arteries upon stimulation by acetylcholine in mice. 30 Finally, CALM1 has been shown to be significant in an association study for adult stroke 31 and is known to be an essential trigger of platelet activation. The abundance of potential risk factors supports a model of heterogeneity as outlined above. To our knowledge there is no comparable cohort of pediatric stroke with suitable DNA samples available, mainly due to the low incidence of the disease and restrictions in several countries with such cohorts to conduct genetic association studies in children.
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In lack of such an independent study sample, we were not able to validate the association by replication analysis at this point in time. And we are aware of the fact that the lack of replication limits our ability to generalize our findings to other cohorts.
In summary, this GWAS provides important insights into the genetic underpinnings of stroke in children. We identified a gene family with several members exhibiting considerably strong association signals in the dataset. The observation of two genes from the same family within the peak signal range is extraordinary and a novel observation in GWAS and suggests a crucial role for the class of ADAMTS metalloproteinases in pediatric stroke pathogenesis. Secondly, we have found a cluster of genetic variants that act on common physiological mechanisms leading to hyperreactive platelet activation and altered vascular function, and are thus conceivable to cause prothrombotic susceptibility in a cumulative fashion.
In conjunction, these results give rise to the hypothesis that a disposition towards a reduced integrity of the endothelial wall as e.g. conferred by ADAMTS defects together with hypersensitive platelet activation and/or vasoconstriction is a major cause of stroke in early childhood. While our cohort is comparable to similar studies in white children 1, 3 , the generalizability of our findings hinges upon future studies using larger study samples with joint analyzes of susceptibility variants. Such studies would also enable the inclusion of intermediate phenotypes and rare genetic variants (identified through next generation sequencing efforts currently underway) to unravel genetic susceptibility and underlying biological pathways.
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